15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 $1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.

Slides:

Advertisements

Similar presentations

Up date on malaria vaccine

Advertisements

1 Workshop on the immunological basis of vaccine efficacy Vaccine and Infectious Disease Institute December 14, 2009 Ira M. Longini, Jr. Center for Statistical.

Veterinary Medicine What’s it all about?.

1. This house is very expensive, I can't it. 2-There are many of the war in Iraq. 3- Ahmad was the only one.

What can we learn from diverse spectrum of HIV/SIV infections? Françoise BARRÉ-SINOUSSI Regulation of Retroviral Infections Unit Department of Virology.

Phase Difference = Phase Difference = 0.05.

DARWIN ANIMAL DOCTORS. Started in 2010 Have treated thousands of native and non- native species Have spayed and neutered hundreds of non-native, invasive.

Dr Himani. Foams or creams that people can use in vagina or rectum during sex to prevent transmission Currently, there is no vaccine to prevent HIV. This.

 In 2001, CDC published an article in the Journal of Virology showing that a single dose of a DNA vaccine could prevent WNV infection in mice and horses.

Research ethics and how health research is reviewed This presentation has been developed to form part of the lesson ‘Research ethics and how health research.

Optimization of Stem cell Therapy for degenerative Epithelial & Muscle Diseases March 2009 – February

Dr Hannah Kibuuka Makerere University Walter Reed Project Presentation at the Uganda Medical Association-Uganda Veterinary Association joint conference.

What Makes a Successful Trial? MorenikeUkpong Nigeria HIV Vaccine and Microbicide Advocacy Group.

INTEGRATED PROJECT MUCOSAL VACCINES FOR POVERTY-RELATED DISEASES MUVAPRED MUVAPRED Project Summary Human Immunodeficiency Virus and Mycobacterium tuberculosis.

Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.

Diseases Learning Targets and Success Criteria. Infection Learning Target I can explain how viruses, bacteria, fungi and parasites may infect the human.

New initiatives for TB vaccines TBVAC Follow-up to the TB vaccine cluster, led by the Pasteur Institute Goal is to take the best new TB vaccines through.

 What types of hazards are presented to employees of a vet clinic?

Methods used to control the spread of infection 2.02 Understand infection control procedures.

Katharine Kripke, Ph.D. Assistant Director, Vaccine Research Program, Division of AIDS, NIAID AIDS Vaccine 2011 Journalist Training Program September 11,

Clinical Trials in Patients with Resected Stage IIB and III Melanoma Craig L. Slingluff, Jr., M.D. Professor of Surgery, University of Virginia Director,

© Nuffield Foundation 2011 Advancing scientific knowledge Studying disease and developing medicines Assessing the safety of chemicals Breeding Destroying.

$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.

Microbicides The Population Council Experience and Future Directions Don E. Waldron Medical Director Don E. Waldron Medical Director.

Group 1 NGO Group (Society for Family Support). Measles is one of the leading causes of death among young children even though a safe and cost- effective.

Diseases and the Immune/Lymphatic System. Define these terms: Put your answers where you would start your notes. Define with your partner using only your.

Biomedical Research Methods

 They are defending 90% to 99% of infections  They prevent diseases for 2.5 millions kids each year  This is equivalent to 285 children saved per hour.

Bugs like these cause yellow Fever.. Yellow fever is a tropical disease that is spread to humans by infected mosquitoes. Many yellow fever infections.

CONTAGIOUS BOVINE PLEUROPNEUMONIA (CBPP). Mycoplasma mycoides subspecies mycoides SC (bovine biotype). subacute or symptomless infections persistence.

Health Vocabulary: 2. Infectious (n/adj) - diseases caused by pathogens that can be spread, from one person to another The disease is dangerous because.

CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.

StageDuration Who the vaccine is tested on Purpose Lab testing 1 year The vaccine will first be tested in the lab on human cells and on animals to make.

Dacy Gaston NSG  According to the CDC (2014)  “Human papillomavirus (pap-ah-LO-mah-VYE-rus) (HPV) is the most common sexually transmitted virus.

Malaria, the vaccine? Professor Cochaud Djientcheu Tchameni Raissa 3 rd year of Pharmacy Set n°2.

DVD: Contagion A brief study of epidemiology …. DVD: Contagion Infectious: capable of spreading disease. also known as communicable.

SB/E 3.03 SB/E 3.03 Category 3 Category 4 Category 5 1pt 1 pt 1 pt 1pt

Methods used to control the spread of infection 2

Methods used to control the spread of infection 2

Tuberculosis prevention

REVOLUTiONiZiNG MALARiA VACCiNATiON

From: Rotarix: A Rotavirus Vaccine for the World

Laboratory diagnosis and biosafety issues of biological warfare agents

Tuberculosis prevention

Japanese Encephalitis (JE) Therapeutics Pipeline is Expected to Witness Many Collaborations in Future.

Communicable Diseases

Efficacy of a Foot-and-Mouth Disease inactivated vaccine (AFTOVAXPUR DOE), administered at a 1 mL dose to sheep Claude Hamers.

Immunology & Public Health

ФОНД ЗА РАЗВОЈ РЕПУБЛИКЕ СРБИЈЕ

Methods used to control the spread of infection 2

RSV Bronchiolitis.

DENGUE VACCINE.

Controlled Human Infection Models

The Different Phases Of Clinical Trials

Louis Pasteur, from crystals of life to vaccination

J.-P. Stahl Clinical Microbiology and Infection

Revision of linezolid disk diffusion quality control guidelines for testing Staphylococcus aureus ATCC 25923: an independent seven-laboratory trial D.J.

Efficacy and Safety of Elbasvir/Grazoprevir in Treatment-Naïve patients with Chronic HCV GT 1, GT 4 and GT 6 Infection (C-CORAL): A Phase III Randomized.

Methods used to control the spread of infection 2

'III \-\- I ', I ,, - -

Medicine: Past and Present

TB VACCINES WORKING GROUP

Reverse Vaccinology: Developing Vaccines in the Era of Genomics

Immunology & Public Health

Laboratory diagnosis and biosafety issues of biological warfare agents

Laboratory diagnosis of Clostridium difficile disease

Vaccinations against respiratory tract infections at Hajj

Every Mother, Every Child: Closing the Gaps in HIV Management

Welcome to Who Wants to be a Millionaire

Presentation transcript:

$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000

$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000

A: A process of testing vaccines in humans B: A process of testing vaccines in animals C: A process of testing vaccines in the laboratory 50: $1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000 Clinical vaccine trials are: A: A process of testing vaccines in humans D: A process of administering vaccines in clinics

$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000

A: Is safe C: protects against infection or disease B: changes behaviours D: causes disease 50: $1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000 A: is safe The main objective of a Phase I clinical trial is to find out if the candidate product:

$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000

A: Is safe C: protects against infection or disease B: changes behaviours D: causes disease 50: $1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000 C: protects against Infection or disease The main objective of a Phase III clinical trial is to find out if the candidate product:

YOU WIN $25,000!